← Insider buys

Andrew Turitz has sold TDOC and made no open-market buys since Mar 2018

EVP, Corporate Development at Teladoc Health, Inc.

SEC CIK 0001726221 · Filings on SEC.gov ↗

$0Bought
$15.9MSold
NoneLast buy

Every filing

29 filings since Mar 2018, newest first

TDOCSell

Teladoc Health, Inc.

EVP, Corporate Development

$151K−50.0%Sep 5
TDOCSell

Teladoc Health, Inc.

EVP, Corporate Development

$82K−14.0%Mar 6
TDOCSell

Teladoc Health, Inc.

EVP, Corporate Development

$97K−14.0%Mar 5
TDOCSell

Teladoc Health, Inc.

SVP - Corporate Development

$47K−7.0%Mar 7
TDOCSell

Teladoc Health, Inc.

SVP - Corporate Development

$46K−7.0%Mar 3
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$89K−8.0%Mar 8
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$123K−13.0%Mar 4
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$718K−34.0%Mar 9
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$794K−25.0%Mar 5
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$156K−7.0%Mar 3
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$278K−26.0%Dec 7
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$278K−26.0%Nov 6
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$470K−34.0%Oct 6
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$460K−34.0%Sep 4
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$493K−34.0%Aug 5
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$1.1M−56.0%Jul 10
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$295K−26.0%Jul 8
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$556K−41.0%Jun 23
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$2.4M−78.0%Apr 17
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$733K−70.0%Dec 10
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$570K−70.0%Sep 11
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$550K−70.0%Jun 19
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$1.8M−89.0%Apr 8
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$137K−70.0%Dec 19
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$526K−87.0%Dec 6
TDOCSell

Teladoc Health, Inc.

SVP - Business Development

$635K−87.0%Sep 5
TDOCSell

Teladoc, Inc.

SVP - Business Development

$821K−92.0%Jul 9
TDOCSell

Teladoc, Inc.

SVP - Business Development

$28K−37.0%Mar 8
TDOCSell

Teladoc, Inc.

SVP - Business Development

$1.5M−100.0%Mar 6
About Andrew Turitz

Turitz Andrew (Drew Turitz) is a corporate insider and senior healthcare executive who served as Executive Vice President, Corporate Development at Teladoc Health, Inc. (TDOC), where he led mergers and acquisitions and strategic partnerships for the virtual care provider.( At Teladoc, he defined M&A and partnership strategy and oversaw the integration of major acquisitions including Livongo, InTouch Health, Advance Medical, and Best Doctors, helping build Teladoc into a leading global telehealth platform.( As an insider, he has reported numerous equity transactions in Teladoc shares, including multiple Form 4–reported sales through 2024 in his capacity as EVP, Corporate Development.(

Turitz is a growth-oriented finance and corporate development leader with more than 20 years of experience across public and private healthcare companies as an executive, investor, board member, and adviser.( Prior to and following his Teladoc tenure, he has held senior roles including Chief Financial Officer at Fuze Health and later CFO at Atropos Health, a data-driven healthcare company.( Earlier in his career, he served as Vice President, Business Development at Healthagen (Aetna, a CVS Health company), focusing on healthcare services and digital health partnerships.( He holds a BA in International Relations from Stanford University and an MBA in Accounting and Finance from Northwestern University’s Kellogg School of Management.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.